From:
$13.86
Prescription required
Brimonidine (Generic Alphagan P): Uses, Dosage, Side Effects, and More
Reviewed by:
From:
$13.86
Prescription required
Brimonidine is a prescription eye medication used to lower intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. As an alpha-2 adrenergic agonist, it reduces fluid production and increases aqueous drainage to prevent optic nerve damage and vision loss. Its Purite preservative system is formulated to be gentler on the eyes than traditional preservatives. Brimonidine is available by prescription only and should be used exactly as directed by an eye care professional to ensure safe and effective pressure control.
Your Prescription
Ready to Fill
Need Help?
Our pharmacists are available 24/7 to answer questions about your medication.
Drug Facts
Generic name
Brimonidine
Brand names
Alphagan P
Drug type
Alpha-2 adrenergic receptor agonist (antiglaucoma agent)
Controlled substance
Not a controlled medication
Dosage forms
Ophthalmic solution (eye drops)
Typical dosage
Brimonidine ophthalmic solution is typically administered in adults as one drop in the affected eye(s) every 8–12 hours, usually twice daily. Pediatric use has not been established for children under 2 years, and it should be used with caution in older children as instructed.
Basics
What Is Brimonidine?
Brimonidine (brimonidine tartrate) is an alpha-2 adrenergic agonist used in ophthalmology to lower intraocular pressure (IOP). It works by reducing aqueous humor production and increasing uveoscleral outflow, helping protect the optic nerve from pressure-related damage.
Brimonidine is commonly prescribed for patients with open-angle glaucoma or ocular hypertension, conditions that can lead to progressive vision loss if left untreated.
As with all ophthalmic treatments, patients should be monitored regularly to ensure continued effectiveness and tolerability.
Note: This medication’s generic and brand-name formulations are used interchangeably throughout this article.
What Is Alphagan P?
Alphagan P is the brand-name ophthalmic formulation of brimonidine tartrate. It is available as an eye drop formulation specifically designed for long-term use in glaucoma management.
Alphagan P delivers the same active ingredient as generic brimonidine but may differ in preservative system and formulation, which can affect tolerability for some patients.
Indications
What Is Brimonidine Used For?
Alphagan P’s primary role is in the management of ocular conditions characterized by elevated intraocular pressure. Maintaining proper intraocular pressure is essential for the health of the optic nerve and overall visual function.
When intraocular pressure is elevated, it can cause irreversible damage, underscoring the importance of medications such as Alphagan P in preserving vision.
Primary Indications
- Treatment of Open-Angle and Normal-Tension Glaucoma: Alphagan P effectively lowers intraocular pressure, a cornerstone of treatment for open-angle glaucoma. Emerging evidence suggests that brimonidine may provide optic nerve neuroprotection by supporting retinal ganglion cell survival, leading some specialists in 2025 to prioritize Alphagan P for normal-tension glaucoma, in which optic nerve damage occurs despite normal IOP levels.
- Management of Ocular Hypertension: Alphagan P is used to manage ocular hypertension, a condition characterized by elevated intraocular pressure without glaucomatous damage. Effective control prevents progression to glaucoma, thereby safeguarding vision.
Alphagan P is an important therapeutic option, particularly for patients who may not tolerate other glaucoma medications, such as prostaglandin analogs or beta-blockers. Additionally, it can be used in combination with other agents to enhance overall pressure-lowering effects when needed.
Mechanism
How Does Brimonidine Work?
Understanding how Alphagan P works is integral to appreciating its role in treating elevated intraocular pressure, which is a major risk factor for glaucoma and related conditions. Its effectiveness is largely due to its mechanism of action and pharmacokinetic profile.
Mechanism of Action
Alphagan P lowers intraocular pressure through two primary actions: reducing aqueous humor production and enhancing uveoscleral outflow. The active ingredient, brimonidine, is an alpha-2 adrenergic receptor agonist.
When applied topically to the eye, brimonidine stimulates these receptors in the ciliary body, leading to a decreased production of aqueous humor—the fluid produced in the eye. It also facilitates increased drainage of the existing fluid from the eye via the uveoscleral pathway.
This dual mechanism effectively reduces intraocular pressure and helps manage both glaucoma and ocular hypertension, thereby minimizing the risk of optic nerve damage and preserving vision.
Pharmacokinetics
Brimonidine, the active compound in Alphagan P, is rapidly absorbed following its application in the eye. Peak intraocular pressure-lowering effects are typically observed within two hours of administration, underscoring the need for regular dosing to maintain consistent pressure control.
The drug’s relatively rapid onset and the need for multiple daily doses highlight the importance of patient adherence to the prescribed regimen. Consistent use as prescribed by an eye care professional ensures optimal therapeutic outcomes and minimizes the potential for progression to more severe disease.
Dosage
Brimonidine Dosages and Administration
Administering Alphagan P requires attention to detail to ensure its effectiveness and prevent contamination or irritation. Proper administration techniques are crucial for maximizing the drug’s benefits and minimizing potential side effects.
Dosage Guidelines
The standard dosage for Alphagan P is 1 drop in the affected eye(s) 3 times daily, approximately every 8 hours. Patients need to adhere to this schedule to maintain effective intraocular pressure control.
Administration Guidelines
Proper use of Alphagan P helps ensure safety and optimal therapeutic benefit. Before applying the drops, individuals should wash their hands thoroughly. The head should be tilted back, and the lower eyelid gently pulled downward to create a small pocket.
One drop is then instilled into this pocket, taking care not to allow the dropper tip to touch the eye or any other surface to avoid contamination. After administration, the bottle should be closed tightly to maintain sterility for future use.
Storage Instructions
Alphagan P should be stored at room temperature, away from moisture and heat. The bottle should always be kept tightly closed when not in use to preserve the solution’s integrity and efficacy.
Get The Right Dose For Less
Why pay retail prices for the same medication?
At Invictus, we source directly from trusted, FDA-approved manufacturers to keep your costs low without sacrificing quality. Whether you need a one-time fill or regular refills, our transparent pricing makes it easy to save every day.
Side Effects
Brimonidine Side Effects and Risks
While Alphagan P is generally well tolerated, like all medications, it can cause side effects. Understanding these effects is important for monitoring treatment and addressing any issues that occur.
Common Side Effects
Most side effects associated with Alphagan P are mild, short-lived, and occur at the site of application. They typically appear soon after instilling the eye drops and improve as the body adjusts to the medication.
- Eye Irritation and Delayed Allergy Risk: Mild stinging, burning, or itching may occur briefly after applying Alphagan P and typically resolves within minutes, but a distinctive delayed allergic reaction can develop 6–9 months into treatment, presenting as red, velvety inflammation of the inner eyelids (follicular conjunctivitis); this late-onset reaction indicates drug allergy rather than infection, and proper drop technique can help minimize early irritation.
- Dry Mouth: Alphagan P may slightly reduce saliva production, resulting in a dry, cottony mouth. Drinking water frequently or using sugar-free gum or lozenges can help ease this discomfort.
- Fatigue and Drowsiness: Some patients may experience fatigue, lightheadedness, or drowsiness after initiating Alphagan P, particularly during the first few days of treatment. This occurs because a small amount of the drug can be absorbed into the bloodstream and subsequently affect the nervous system. Until patients understand how the medication affects them, they should exercise caution when driving, operating machinery, or performing tasks that require sustained attention.
These mild side effects often improve over time. However, if they persist or worsen, patients should consult their healthcare provider to determine if dosage adjustments or alternative therapies are needed.
Serious Side Effects
Though rare, serious reactions can occur and should be treated as medical emergencies or prompt immediate medical evaluation:
- Severe Allergic Reactions: Some individuals may develop signs of an allergic response, such as eye redness, swelling of the eyelids or face, rash, itching, or difficulty breathing. These symptoms may indicate hypersensitivity to brimonidine or other formulation ingredients and require discontinuation and urgent medical care.
- Persistent Eye Pain or Vision Changes: Ongoing eye pain, blurred vision, light sensitivity, or sudden vision changes may indicate a more serious ocular condition or an adverse reaction. If these occur, the patient should stop using the medication and contact an ophthalmologist immediately.
- Unusual or Extreme Tiredness or Weakness: In rare cases, systemic absorption of Alphagan P can affect the central nervous system, leading to marked fatigue, dizziness, or low blood pressure. These symptoms warrant medical review, particularly in older adults or patients taking other sedating medications.
Monitoring and promptly reporting any side effects are critical components of effective therapy with Alphagan P. Healthcare providers can adjust the treatment plan as necessary to optimize benefits and minimize risks.
Safety Monitoring
Regular follow-up appointments with an ophthalmologist are essential to ensure that Alphagan P is effectively controlling intraocular pressure without causing adverse effects. Patients should:
- Report any persistent discomfort, redness, or visual changes.
- Inform their provider of all other eye drops or medications they are using to avoid harmful interactions.
- Use the medication exactly as prescribed, typically twice daily, and avoid touching the dropper tip to prevent contamination.
Prompt recognition and reporting of side effects allow healthcare providers to adjust treatment or switch medications as needed, helping maintain both eye health and overall safety.
Interactions
Brimonidine Interactions
Alphagan P can interact with other medications and affect how they work—or be affected by them.
Drug Interactions
Certain medications may alter the way Alphagan P functions or increase its sedative and cardiovascular effects. Patients should be aware of the following key interactions:
- Antihypertensives (Blood Pressure Medications): Alphagan P has mild systemic effects that can lower blood pressure. When used alongside antihypertensive drugs—such as beta-blockers, ACE inhibitors, ARBs, or diuretics—these effects may combine, resulting in excessive hypotension (low blood pressure). Symptoms may include dizziness, lightheadedness, or fainting, particularly when standing up suddenly. Patients taking both medications should monitor their blood pressure regularly and report any persistent dizziness or weakness to their healthcare provider.
- Central Nervous System (CNS) Depressants: Alphagan P may cause mild sedation or drowsiness, particularly upon initiation. When combined with other CNS depressants, such as alcohol, benzodiazepines (e.g., diazepam or lorazepam), opioids, sedating antihistamines (e.g., diphenhydramine), or sleep aids, these effects can be amplified. This can lead to excessive sleepiness, slowed reflexes, or impaired coordination, increasing the risk of accidents or falls. Patients should avoid alcohol and use caution when combining Alphagan P with any sedating medications.
- Tricyclic Antidepressants (TCAs): Some antidepressants, such as amitriptyline or nortriptyline, may reduce the effectiveness of Alphagan P or worsen side effects, as they can interfere with the drug’s mechanism on the nervous system. If patients are taking antidepressants, they should inform their ophthalmologist, who may adjust the treatment plan accordingly.
- Monoamine Oxidase Inhibitors (MAOIs): Although rare, patients using MAO inhibitors (such as phenelzine, selegiline, or tranylcypromine) should exercise caution. These drugs can prolong or intensify Alphagan P’s effects on blood pressure and the central nervous system, potentially leading to unstable blood pressure or excessive drowsiness. Concurrent use should be avoided unless under close physician supervision.
For these reasons, patients should inform their healthcare providers of all medications they are taking, including over-the-counter medications. This helps prevent harmful interactions and ensures a balanced and effective treatment plan.
Contraindications
Brimonidine Contraindications
Contraindications are conditions or factors that indicate a drug should not be used. Awareness of contraindications helps prevent complications and adverse reactions.
Absolute Contraindications
Some patients should not use Alphagan P due to the risk of serious adverse effects or reduced safety:
- Allergies or Hypersensitivity: Individuals who are allergic to brimonidine or any other components of Alphagan P should not use this medication. Signs of an allergic reaction may include redness, itching, swelling around the eyes or face, rash, or difficulty breathing. Patients with a history of medication allergies should inform their eye doctor before starting treatment so that alternative glaucoma therapies can be considered.
- Cardiovascular Concerns: Alphagan P may have mild systemic effects because a small amount of the medication can enter the bloodstream after topical application. This can occasionally lead to changes in blood pressure or heart rate. For this reason, patients with severe cardiovascular disease, orthostatic hypotension, or heart rhythm abnormalities (arrhythmias) should use Alphagan P only under close medical supervision. Regular monitoring of blood pressure and heart rate can help detect potential complications early.
Relative Contraindications and Cautions
While not absolute contraindications, some individuals should exercise extra caution when using Alphagan P:
- Depression or Use of Certain Antidepressants: Alphagan P acts on alpha-2 adrenergic receptors, similar to some antidepressants. Patients taking monoamine oxidase inhibitors (MAOIs) or tricyclic antidepressants (TCAs) may experience increased sedation or unstable blood pressure. These medications can also reduce the effectiveness of Alphagan P. A healthcare provider should review all psychiatric medications before starting treatment.
- Severe Kidney or Liver Impairment: Because a small amount of brimonidine may be systemically absorbed and processed by the liver and kidneys, patients with impaired liver or kidney function should use this drug cautiously under medical supervision.
Pediatric Safety Warning (Severe CNS Depression): Alphagan P is strictly contraindicated in children under 2 years old and requires extreme caution in children ages 2–6, as even small amounts can cross the blood–brain barrier and cause profound central nervous system depression, including extreme drowsiness, low blood pressure, slowed or stopped breathing, coma, or “floppy baby” syndrome. If prescribed to older children, parents must use punctal occlusion for 2 minutes after dosing to limit systemic absorption and reduce life-threatening risk.
Ready to Start Saving?
No one should overpay for safe, effective medication. By cutting out middlemen and working directly with trusted, FDA-approved manufacturers, Invictus offers the same high-quality medicines you’d find at big retail pharmacies—at a fraction of the price.
Whether you choose brand-name or generic, we’ll deliver it quickly, affordably, and right to your door. Maybe that’s why most patients who switch to Invictus never look back.
Frequently Asked Questions (FAQs)
Didn’t see the answers you’re looking for in this article? Check out this comprehensive FAQ for more details.
Administration & Dosage
Alphagan P is intended for ophthalmic use as eye drops. When applying Alphagan P, wash your hands thoroughly first to ensure cleanliness and prevent contamination. Tilt your head back slightly and pull down your lower eyelid to form a small pocket. Holding the dropper above the eye, squeeze out the prescribed number of drops. Be careful not to let the dropper touch your eye or any other surface to maintain sterility. After application, gently close your eye and press on the inner corner for a minute or two, allowing the medicine to spread evenly.
The typical dosage for Alphagan P is one drop in the affected eye(s) three times a day. These applications should be spaced roughly eight hours apart to maintain consistent intraocular pressure reduction. Always follow the specific dosage instructions provided by your healthcare provider, as they may tailor the regimen to your individual needs and response to treatment.
Alphagan P can be used in both eyes if recommended by your healthcare provider. It is commonly prescribed for both eyes when conditions such as bilateral open-angle glaucoma or ocular hypertension are present. Make sure to apply the drops as instructed to each affected eye for effective treatment.
Your ophthalmologist should determine the duration of treatment with Alphagan P. It is essential to adhere to the prescribed treatment plan and not to discontinue use without consulting your healthcare provider, even if you notice an improvement in symptoms. Abruptly stopping the medication may result in a rebound increase in intraocular pressure.
Alphagan P should be stored at room temperature, away from excessive humidity and heat. Ensure the bottle is tightly closed when not in use to prevent contamination and preserve its effectiveness. Do not store in the bathroom. Keep the medicine out of the reach of children.
Uses & Mechanism of Action
Alphagan P is primarily used to lower intraocular pressure in individuals suffering from open-angle glaucoma or ocular hypertension. By reducing intraocular pressure, the medication helps slow the progression of these eye conditions and minimizes the risk of optic nerve damage and potential vision loss.
The active ingredient in Alphagan P is brimonidine, an alpha-adrenergic agonist. This medication works by decreasing the production of aqueous humor, the fluid in the eye, and by enhancing its drainage from the eye. The dual action effectively lowers intraocular pressure and helps manage conditions like glaucoma and ocular hypertension.
Alphagan P is not classified as a long-acting medication. Its effects require multiple administrations throughout the day to maintain stable intraocular pressure. Typically, patients are advised to use the drops three times daily at evenly spaced intervals.
Alphagan P is available only by prescription. A healthcare professional must evaluate your condition and determine if Alphagan P is appropriate for your treatment plan. This ensures that the medication is used safely and effectively under medical supervision.
The main therapeutic benefit of Alphagan P is the reduction of intraocular pressure in patients with conditions like open-angle glaucoma and ocular hypertension. Lowering eye pressure is critical in preventing optic nerve damage and preserving vision. By effectively managing intraocular pressure, Alphagan P helps reduce the risk of vision impairment and enhances the quality of life for patients with these eye conditions.
Side Effects & Safety
While Alphagan P is generally well-tolerated, some patients may experience side effects. Common ones include eye redness, a burning or stinging sensation upon application, dry mouth, and blurred vision. These side effects are typically mild and tend to diminish as the body adjusts to the medication. If they persist or worsen, consulting a healthcare provider is advisable.
Though rare, serious side effects can occur and may require immediate medical attention. Such reactions include severe allergic reactions such as swelling of the face or tongue, difficulty breathing, or intense dizziness. These symptoms may indicate hypersensitivity to the medication and require urgent care.
The use of Alphagan P in children has not been extensively studied, making its safety and efficacy in pediatric populations uncertain. It's crucial to discuss with a healthcare provider before administering this medication to children, as they can provide guidance tailored to the child's specific needs and condition.
Pregnant women should use Alphagan P only if the potential benefits justify the potential risks to the fetus. Its use during pregnancy should be decided in consultation with a healthcare provider, who can evaluate the risks and benefits specific to the individual's health status.
It is unclear whether Alphagan P passes into breast milk. Therefore, caution should be exercised when it is administered to nursing mothers. A healthcare provider can advise on whether to continue the medication, weighing the benefits to the mother against any potential risks to the breastfeeding infant.
Interactions & Contraindications
Alphagan P may interact with certain medications, including other central nervous system depressants and antihypertensive drugs, potentially enhancing their effects. It is crucial to inform your healthcare provider about all medications you are currently using, including prescription, over-the-counter, and herbal products, to avoid adverse interactions.
Alcohol may enhance some of the side effects of Alphagan P, such as increased drowsiness or dizziness. Limiting alcohol consumption is often advisable when undergoing treatment with this medication to ensure safety and avoid complications.
Individuals with severe cardiovascular diseases, depression, or orthostatic hypotension should use Alphagan P with caution. Your healthcare provider can assess the risks versus benefits based on your overall health and medical history before prescribing the medication.
Alphagan P can potentially interact with over-the-counter medications. It's important to discuss all drugs you are taking, including non-prescription ones, with your healthcare provider. They can provide guidance on safe drug combinations and any potential risks associated with interactions.
In the event of an overdose, particularly if swallowed, seek immediate medical attention or contact a Poison Control Center. Symptoms may include significant sedation, respiratory depression, or cardiovascular effects. Prompt medical evaluation is necessary to address any complications resulting from an overdose.
Generic & Alternatives
The generic form of Alphagan P is brimonidine. This alternative contains the same active ingredient in equivalent dosages and can offer a more cost-effective option while maintaining similar therapeutic efficacy.
The cost of Alphagan P can vary based on factors such as your location, insurance coverage, and the pharmacy you visit. Typically, the branded formulation is more expensive due to marketing and development costs. The generic version generally provides significant savings.
The high cost of Alphagan P is often attributed to its brand recognition, research, and marketing expenses. Pharmaceutical pricing is influenced by factors such as formulation and market demand. Opting for the generic version of brimonidine can help reduce costs for patients.
Several alternatives exist for managing intraocular pressure in glaucoma. These include medications like prostaglandin analogs (e.g., latanoprost), beta-blockers, and carbonic anhydrase inhibitors. Your doctor can help determine the most suitable option based on the specifics of your condition and response to treatment.
Alphagan P is not preservative-free, but it uses Purite®, a preservative that breaks down into natural tear components when exposed to light. Purite is generally less irritating than traditional preservatives such as benzalkonium chloride (BAK), making Alphagan P a preferred option for patients who require chronic eye-drop therapy or who experience sensitivity with other glaucoma medications.
Disclaimer
The information provided on this page is for general informational purposes only and is not intended as medical advice. Always consult with a licensed healthcare provider before starting, stopping, or changing any medication regimen. While Invictus strives to provide accurate and up-to-date information, individual health conditions and circumstances vary. The prices, availability, and descriptions of all medications on this page are subject to change.
Your Prescription
Ready to Fill
Need Help?
Our pharmacists are available 24/7 to answer questions about your medication.
